Results 111 to 120 of about 6,997 (186)

Application of HRCT-based radiomics to predict interstitial lung disease for juvenile dermatomyositis. [PDF]

BMC Pediatr
Liu L, Hu M, Zhou Y, Zheng F, Ma X, Yang L, Xu Y, Teng L, Hu B, Lu M, Xu X.   +10 more
europepmc   +1 more source

Juvenile dermatomyositis [PDF]

, 2020
openaire   +1 more source

Distinct by Design: Unraveling the Unique Clinical and Transcriptomic Identity of Juvenile Scleromyositis Overlap Compared to Juvenile Systemic Sclerosis and Juvenile Dermatomyositis: Implications for Care and Pathogenesis. [PDF]

ACR Open Rheumatol
Robinson AD, Pain CE, Morgan GA, Sanyal A, Chaparala S, Pachman LM, Torok KS.   +6 more
europepmc   +1 more source

Approach to Janus kinase inhibition for juvenile dermatomyositis among CARRA and PReS providers. [PDF]

Rheumatology (Oxford)
Sherman MA, Nicolai R, Datyner EK, Rosina S, Hamilton A, Ardalan K, Bader-Meunier B, Brown AG, Jansen MHA, Kim S, Lang B, Campanilho-Marques R, McCann LJ, Sanner H, Veldkamp SR, Wilkinson MGL, Yi BY, Kim H, Tarvin SE, Papadopoulou C, CARRA JDM Therapeutics Workgroup and the PReS JDM Working Party.   +20 more
europepmc   +1 more source

Physical Growth Dynamics of Children With Juvenile Dermatomyositis. [PDF]

Cureus
Soni K, Kaur H, Gupta A, Singh S, Saha SC, Bhalla A.   +5 more
europepmc   +1 more source

Juvenile Dermatomyositis Triggered by Influenza B: A Case Report on Viral-Induced Autoimmunity. [PDF]

Pediatr Dermatol
Dans-Caballero S, Juan-Cencerrado M, Mochón-Jiménez C, Roldán-Molina R, Pérez-Guijo VC.   +4 more
europepmc   +1 more source

Juvenile dermatomyositis in Oman: clinical patterns and disease trajectory from a National cohort. [PDF]

Pediatr Rheumatol Online J
Abdwani R, Mal MJ, Al Masroori E, Al Jashmi R, Abrawi SA, Al-Zakwani I.   +5 more
europepmc   +1 more source

Tofacitinib: a promising agent for the treatment of persistent rashes in juvenile dermatomyositis. [PDF]

World J Pediatr
Chen ZY, Zhang TN, Li J, Zhang ZJ, Song HM.   +4 more
europepmc   +1 more source

Achieving Medication-Free Remission in Patients With Juvenile Dermatomyositis. [PDF]

ACR Open Rheumatol
Maccora I, Brunner HI, Cassedy A, Altaye M, Quinlan-Waters M, Lovell DJ, Grom A, Angeles-Han ST.   +7 more
europepmc   +1 more source

Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile Dermatomyositis. [PDF]

J Clin Med
Buzoianu O, Satirer Ö, Kuemmerle-Deschner JB, Reiser C.   +3 more
europepmc   +1 more source